Detailed information for compound 216470

Basic information

Technical information
  • TDR Targets ID: 216470
  • Name: (2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S)-2-( methylamino)-2-oxo-1-phenylethyl]-2,5-bis(phe nylmethoxy)hexanediamide
  • MW: 682.762 | Formula: C38H42N4O8
  • H donors: 6 H acceptors: 6 LogP: 2.53 Rotable bonds: 21
    Rule of 5 violations (Lipinski): 3
  • SMILES: CNC(=O)[C@H](c1ccccc1)NC(=O)[C@@H]([C@@H]([C@H]([C@H](C(=O)N[C@@H](c1ccccc1)C(=O)NC)OCc1ccccc1)O)O)OCc1ccccc1
  • InChi: 1S/C38H42N4O8/c1-39-35(45)29(27-19-11-5-12-20-27)41-37(47)33(49-23-25-15-7-3-8-16-25)31(43)32(44)34(50-24-26-17-9-4-10-18-26)38(48)42-30(36(46)40-2)28-21-13-6-14-22-28/h3-22,29-34,43-44H,23-24H2,1-2H3,(H,39,45)(H,40,46)(H,41,47)(H,42,48)/t29-,30-,31+,32+,33+,34+/m0/s1
  • InChiKey: SUXVPHKLQQOPHJ-XLTUSUNSSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • (2R,3R,4R,5R)-2,5-dibenzyloxy-3,4-dihydroxy-N,N'-bis[(1S)-2-(methylamino)-2-oxo-1-phenyl-ethyl]hexanediamide
  • (2R,3R,4R,5R)-2,5-dibenzyloxy-3,4-dihydroxy-N,N'-bis[(1S)-2-(methylamino)-2-oxo-1-phenylethyl]hexanediamide
  • (2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S)-2-(methylamino)-2-oxo-1-phenyl-ethyl]-2,5-bis(phenylmethoxy)hexanediamide
  • (2R,3R,4R,5R)-2,5-dibenzoxy-3,4-dihydroxy-N,N'-bis[(1S)-2-keto-2-(methylamino)-1-phenyl-ethyl]adipamide
  • (2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S)-2-methylamino-2-oxo-1-phenylethyl]-2,5-bis(phenylmethoxy)hexanediamide
  • (2R,3R,4R,5R)-3,4-dihydroxy-N,N'-bis[(1S)-2-methylamino-2-oxo-1-phenyl-ethyl]-2,5-bis(phenylmethoxy)hexanediamide
  • (2R,3R,4R,5R)-2,5-bis(benzyloxy)-3,4-dihydroxy-N,N'-bis[(1S)-2-keto-2-methylamino-1-phenyl-ethyl]adipamide
  • AIDS-060867
  • AIDS060867
  • N1,N6-Di[(1S)-1-phenyl-1-(methylcarbamoyl)propyl]-(2R,3R,4R,5R)-2,5-di(benzyloxy)-3,4-dihydroxyhexanediamide

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Human immunodeficiency virus 1 Human immunodeficiency virus type 1 protease Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Schistosoma mansoni intracisternal A-particle retropepsin (A02 family) Get druggable targets OG5_131408 All targets in OG5_131408
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Trypanosoma brucei variant surface glycoprotein (VSG), putative Human immunodeficiency virus type 1 protease   99 aa 80 aa 27.5 %
Echinococcus multilocularis Chromobox protein 3 Human immunodeficiency virus type 1 protease   99 aa 95 aa 28.4 %
Giardia lamblia DNA-directed RNA polymerase subunit D Human immunodeficiency virus type 1 protease   99 aa 90 aa 27.8 %
Entamoeba histolytica retroviral aspartyl protease domain-containing protein Human immunodeficiency virus type 1 protease   99 aa 103 aa 31.1 %
Candida albicans dethiobiotin synthetase Human immunodeficiency virus type 1 protease   99 aa 90 aa 22.2 %
Entamoeba histolytica retroviral aspartyl protease domain-containing protein Human immunodeficiency virus type 1 protease   99 aa 103 aa 31.1 %
Candida albicans dethiobiotin synthetase Human immunodeficiency virus type 1 protease   99 aa 90 aa 22.2 %
Mycobacterium leprae Hypothetical protein Human immunodeficiency virus type 1 protease   99 aa 86 aa 27.9 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Toxoplasma gondii PAN domain-containing protein 0.139 0.495 1
Plasmodium falciparum cysteine repeat modular protein 1 0.1071 0.3383 0.5
Loa Loa (eye worm) TK/ROR protein kinase 0.1071 0.3383 0.3397
Brugia malayi Protein kinase domain containing protein 0.1071 0.3383 0.3397
Plasmodium vivax cysteine repeat modular protein 1, putative 0.1071 0.3383 0.5
Trypanosoma cruzi hypothetical protein, conserved 0.1071 0.3383 0.5
Onchocerca volvulus 0.2026 0.8077 0.811
Brugia malayi Trypsin family protein 0.2409 0.996 1
Echinococcus granulosus tissue type plasminogen activator 0.1071 0.3383 1
Onchocerca volvulus 0.1071 0.3383 0.3397
Onchocerca volvulus 0.2409 0.996 1
Mycobacterium ulcerans hypothetical protein 0.0383 0 0.5
Loa Loa (eye worm) hypothetical protein 0.2409 0.996 1
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) 0.0387 0.002 0.002
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) 0.2409 0.996 0.996
Toxoplasma gondii PAN domain-containing protein 0.139 0.495 1
Loa Loa (eye worm) hypothetical protein 0.2409 0.996 1
Loa Loa (eye worm) hypothetical protein 0.1071 0.3383 0.3397
Schistosoma mansoni hypothetical protein 0.1071 0.3383 0.3383
Echinococcus multilocularis tissue type plasminogen activator 0.1071 0.3383 1
Brugia malayi Kringle domain containing protein 0.1071 0.3383 0.3397
Schistosoma mansoni intracisternal A-particle retropepsin (A02 family) 0.1528 0.5627 0.5627
Leishmania major hypothetical protein, conserved 0.1071 0.3383 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) uM inhibitory activity against purified HIV-1 protease in a standardized spectrophotometric assay expressed in E. coli; ni=no inhibition ChEMBL. 9748353
IC50 (binding) 0 uM inhibitory activity against purified HIV-1 protease in a standardized spectrophotometric assay expressed in E. coli; ni=no inhibition ChEMBL. 9748353
Kd (binding) = 27.4 nM Equilibrium constant for the interaction between inhibitor and HIV-1 Protease ChEMBL. 12459011
Kd (binding) = 27.4 nM Equilibrium constant for the interaction between inhibitor and HIV-1 Protease ChEMBL. 12459011
Ki (binding) = 2.3 nM Inhibition constant against HIV-1 Protease ChEMBL. 12459011
Ki (binding) = 2.3 nM Inhibitory activity against purified HIV-1 protease expressed in E. coli in sensitive fluorometric assay ChEMBL. 9748353
Ki (binding) = 2.3 nM Inhibition constant against HIV-1 Protease ChEMBL. 12459011
Ki (binding) = 2.3 nM Inhibitory activity against purified HIV-1 protease expressed in E. coli in sensitive fluorometric assay ChEMBL. 9748353
koff (binding) = 13.7 s-1 Dissociation rate constant for the interaction between inhibitor and HIV-1 protease ChEMBL. 12459011
kon (binding) = 205000000 M-1 s-1 Association rate constant for the interaction between inhibitor and HIV-1 protease ChEMBL. 12459011
k_off (binding) = 13.7 s-1 Dissociation rate constant for the interaction between inhibitor and HIV-1 protease ChEMBL. 12459011
k_on (binding) = 205000000 M-1 s-1 Association rate constant for the interaction between inhibitor and HIV-1 protease ChEMBL. 12459011

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

2 literature references were collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.